Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Public ClinicalTrials.gov record NCT07259304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors: A Longitudinal Study
Study identification
- NCT ID
- NCT07259304
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- University of Southern California
- Other
- Enrollment
- 250 participants
Conditions and interventions
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Central Nervous System Neoplasm
- Clinical Stage I Cutaneous Melanoma AJCC v8
- Clinical Stage IA Cutaneous Melanoma AJCC v8
- Clinical Stage IB Cutaneous Melanoma AJCC v8
- Clinical Stage II Cutaneous Melanoma AJCC v8
- Clinical Stage IIA Cutaneous Melanoma AJCC v8
- Clinical Stage IIB Cutaneous Melanoma AJCC v8
- Clinical Stage IIC Cutaneous Melanoma AJCC v8
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Hodgkin Lymphoma
- Malignant Bone Neoplasm
- Malignant Brain Neoplasm
- Malignant Solid Neoplasm
- Malignant Testicular Neoplasm
- Non-Hodgkin Lymphoma
- Pathologic Stage I Cutaneous Melanoma AJCC v8
- Pathologic Stage IA Cutaneous Melanoma AJCC v8
- Pathologic Stage IB Cutaneous Melanoma AJCC v8
- Pathologic Stage II Cutaneous Melanoma AJCC v8
- Pathologic Stage IIA Cutaneous Melanoma AJCC v8
- Pathologic Stage IIB Cutaneous Melanoma AJCC v8
- Pathologic Stage IIC Cutaneous Melanoma AJCC v8
- Pathologic Stage III Cutaneous Melanoma AJCC v8
- Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
- Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
- Pathologic Stage IIID Cutaneous Melanoma AJCC v8
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
- Stage I Cervical Cancer AJCC v8
- Stage I Colorectal Cancer AJCC v8
- Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
- Stage I Ovarian Cancer AJCC v8
- Stage I Thyroid Gland Medullary Carcinoma AJCC v8
- Stage I Uterine Corpus Cancer AJCC v8
- Stage IA Cervical Cancer AJCC v8
- Stage IA Ovarian Cancer AJCC v8
- Stage IA Uterine Corpus Cancer AJCC v8
- Stage IA1 Cervical Cancer AJCC v8
- Stage IA2 Cervical Cancer AJCC v8
- Stage IB Cervical Cancer AJCC v8
- Stage IB Ovarian Cancer AJCC v8
- Stage IB Uterine Corpus Cancer AJCC v8
- Stage IB1 Cervical Cancer AJCC v8
- Stage IB2 Cervical Cancer AJCC v8
- Stage IC Ovarian Cancer AJCC v8
- Stage II Cervical Cancer AJCC v8
- Stage II Colorectal Cancer AJCC v8
- Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
- Stage II Ovarian Cancer AJCC v8
- Stage II Thyroid Gland Medullary Carcinoma AJCC v8
- Stage II Uterine Corpus Cancer AJCC v8
- Stage IIA Cervical Cancer AJCC v8
- Stage IIA Colorectal Cancer AJCC v8
- Stage IIA Ovarian Cancer AJCC v8
- Stage IIA1 Cervical Cancer AJCC v8
- Stage IIA2 Cervical Cancer AJCC v8
- Stage IIB Cervical Cancer AJCC v8
- Stage IIB Colorectal Cancer AJCC v8
- Stage IIB Ovarian Cancer AJCC v8
- Stage IIC Colorectal Cancer AJCC v8
- Stage III Cervical Cancer AJCC v8
- Stage III Colorectal Cancer AJCC v8
- Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
- Stage III Ovarian Cancer AJCC v8
- Stage III Thyroid Gland Medullary Carcinoma AJCC v8
- Stage III Uterine Corpus Cancer AJCC v8
- Stage IIIA Cervical Cancer AJCC v8
- Stage IIIA Colorectal Cancer AJCC v8
- Stage IIIA Ovarian Cancer AJCC v8
- Stage IIIA Uterine Corpus Cancer AJCC v8
- Stage IIIA1 Ovarian Cancer AJCC v8
- Stage IIIA2 Ovarian Cancer AJCC v8
- Stage IIIB Cervical Cancer AJCC v8
- Stage IIIB Colorectal Cancer AJCC v8
- Stage IIIB Ovarian Cancer AJCC v8
- Stage IIIB Uterine Corpus Cancer AJCC v8
- Stage IIIC Colorectal Cancer AJCC v8
- Stage IIIC Ovarian Cancer AJCC v8
- Stage IIIC Uterine Corpus Cancer AJCC v8
- Stage IIIC1 Uterine Corpus Cancer AJCC v8
- Stage IIIC2 Uterine Corpus Cancer AJCC v8
Interventions
- Medical Device Usage and Evaluation Other
- Quality-of-Life Assessment Other
- Survey Administration Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 39 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 23, 2021
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2027
- Last update posted
- Dec 1, 2025
2021 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07259304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07259304 live on ClinicalTrials.gov.